China SXT Pharmaceuticals, Inc.
SXTC
$1.50
$0.021.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 9.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 9.89% | |||
| Cost of Revenue | 0.00% | -2.30% | |||
| Gross Profit | 0.00% | 72.55% | |||
| SG&A Expenses | 0.00% | 194.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 101.23% | |||
| Operating Income | 0.00% | -219.99% | |||
| Income Before Tax | 0.00% | -211.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -211.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -211.61% | |||
| EBIT | 0.00% | -219.99% | |||
| EBITDA | 0.00% | -255.98% | |||
| EPS Basic | 0.00% | 48.47% | |||
| Normalized Basic EPS | 0.00% | 48.46% | |||
| EPS Diluted | 0.00% | 48.47% | |||
| Normalized Diluted EPS | 0.00% | 48.46% | |||
| Average Basic Shares Outstanding | 0.00% | 504.78% | |||
| Average Diluted Shares Outstanding | 0.00% | 504.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||